295
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

The activity of ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa

, , , &
Pages 386-389 | Received 11 Dec 2020, Accepted 17 Dec 2020, Published online: 11 Jan 2021
 

Acknowledgements

This study was supported by Pfizer.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.